DY
TNDM icon

Dowling & Yahnke’s Tandem Diabetes Care TNDM Stock Holding History

Dowling & Yahnke’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,757
Closed -$13K – 295
2017
Q3 		$13K Hold
1,757
– – ﹤0.01% 279
2017
Q2 		$14K Hold
1,757
– – ﹤0.01% 275
2017
Q1 		$21K Hold
1,757
– – ﹤0.01% 275
2016
Q4 		$38K Hold
1,757
– – ﹤0.01% 262
2016
Q3 		$135K Hold
1,757
– – 0.02% 256
2016
Q2 		$132K Buy
+1,757
New +$141K 0.02% 261
2014
Q4 		– Sell
-1,014
Closed -$136K – 262
2014
Q3 		$136K Hold
1,014
– – 0.02% 247
2014
Q2 		$165K Buy
+1,014
New +$173K 0.02% 263

Other funds holding TNDM

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Dowling & Yahnke's TNDM Position: Q4 2017 in Review

Dowling & Yahnke sold out of Tandem Diabetes Care (TNDM) in Q4 2017, closing a stake of 1,757 shares — an estimated $13K sold.

Dowling & Yahnke first reported a position in TNDM in Q2 2014 and held it in 8 quarters. The position peaked at $165K in Q2 2014. 42 funds tracked by Wall St. Rank hold TNDM as of Q4 2017.

  • Dowling & Yahnke reported no remaining Tandem Diabetes Care position as of Q4 2017 after selling out during the quarter.
  • Dowling & Yahnke sold 1,757 Tandem Diabetes Care shares in Q4 2017, an estimated $13K.
  • Dowling & Yahnke first reported a position in Tandem Diabetes Care in Q2 2014 and held it in 8 quarters.
  • Dowling & Yahnke's Tandem Diabetes Care position peaked at $165K in Q2 2014.
  • 42 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2017.

Based on Dowling & Yahnke's 13F filing for Q4 2017, filed 2 Feb 2018.